Search database
Filter
4439
Text search: medicines use
Featured
Language
Document type
2339
736
631
249
186
109
77
47
22
18
13
9
2
Countries
233
178
146
110
102
101
89
89
84
83
83
82
73
71
70
68
68
65
59
56
54
45
44
39
39
36
34
33
27
25
23
22
22
21
21
20
20
20
20
20
19
19
19
18
16
15
14
13
13
12
12
12
11
11
9
9
9
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
682
256
156
155
126
94
90
82
62
33
30
30
30
24
24
23
23
22
21
20
19
19
19
19
17
17
16
16
16
16
16
16
15
14
14
14
13
13
13
13
12
12
12
12
11
11
11
11
10
10
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1780
412
270
201
94
87
52
2
2
2
Toolboxes
359
341
276
276
270
212
133
124
105
101
94
88
87
85
75
66
44
37
19
12
12
11
7
2
 Add to my MEDBOX

List of Medicines for Ethiopia

Food, Medicine and Healthcare Administration and Control Authority of Ethiopia (2010) C1
6th edition
 Download
  View PDF
 Add to my MEDBOX

List of Essential Medicines for Children of India

Indian Academy of Pediatrics (2011) C1
 Add to my MEDBOX

Use of Convalescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks

World Health Organization (2014)
This interim guidance to national health authorities and blood transfusion services outlines the steps required to collect convalescent whole blood (CWB) or plasma (CP) from Ebola virus disease (EVD) recovered patients for transfusion to patients with early EVD, as an empirical treatment modality. ... more
 Download
  View PDF
 Add to my MEDBOX

G2 Substance Use Disorders: Cannabis Use and Misuse

Alan J Budney & Catherine Stanger IACAPAP (2015) C1
 Add to my MEDBOX

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Medical eligibility criteria for contraceptive use

World Health Organization (2015)
This executive summary contains all the new recommendations that will be incorporated into the fifth edition of the Medical eligibility criteria (MEC) for contraceptive use. In addition to the recommendations themselves, the summary provides an intr ... more
 Download
  View PDF
 Add to my MEDBOX

How to take medicines safely

German Agency for Quality in Medicine (ÄZQ) (2011) C1
Patient information on safe medical treatment. Available in: Arabic, English, French, Russian, Spanish, Turkish, German. This is the English version. For other language versions visit: http://www.patienten-information.de/kurzinformationen/arzneimittel-und-impfungen/sichere-arzneimitteltherapie
 Download
  View PDF
 Add to my MEDBOX

Nigeria: National Quality Assurance Policy For Medicines and Other Health Products

Federal Ministry of Health, Nigeria (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Selected Practice Recommendations for Contraceptive Use

Erin Berry-Bibee, Melissa Chen, Kathryn Curtis et al. World Health Organization (WHO) (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Evaluation of the Affordable Medicines Programme in Ukraine

World Health Organization WHO, Regional Office of Europe (2019) C_WHO
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatme ... more
 Add to my MEDBOX

List of Medicines for Drug Shop , Ethiopia (LMDS)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2012) C1
Fourth edition
 Add to my MEDBOX

List of Medicines for Community Pharmacy, Ethiopia (LMCP)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2012) C1
Fourth Edition
 Add to my MEDBOX

List of Medicines for Rural Drug Vendor, Ethiopia (LMRDV)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2011) C1
Fourth edition
 Download
  View PDF
 Add to my MEDBOX

Access to medicines: making market forces serve the poor

World Health Organization WHO (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, 12 September 2019

Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children AIDSinfo (2019) CC
Updated guidelines
 Download
  View PDF
 Add to my MEDBOX

Use of Antenatal Corticosteroids in Preterm Labour

Child Health Division, Ministry of Health and Social Welfare, Government of India (2014) C1
Operational Guidelines
 Download
  View PDF
 Add to my MEDBOX

Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children

Unicef, World Health Organization (2017) C_WHO
 External Link
 Add to my MEDBOX

Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis

K.L Tang, N.P Caffrey, D.B Nóbrega, et al. (2017) CC
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR DESTRUCTION OF MEDICINES AND HEALTH PRODUCTS (Malawi)

Pharmacy, Medicines & Poisons Board (2015) C2
PMPB/INS-GUIDE/04
 Download
  View PDF
 Add to my MEDBOX

STANDARD TREATMENT GUIDELINES AND ESSENTIAL MEDICINES LIST FOR LESOTHO

Ministry of Health and Social Welfare (MoHSW), Kingdom of Lesotho (2005) C2
 Download
  View PDF
 Add to my MEDBOX

National Standard Therapeutic Guidelines and Essential Medicines List Liberia 2017, 2nd ed.
recommended

Republic of Libera, Ministry for Health and Social Welfare (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Conservation and Sustainable Use of Traditional Medicinal Plants in Zimbabwe

Chapeyama, Oliver (2009) C1
Final Evaluation
The project objectives were to promote the conservation, sustainable use and cultivation of endangered medicinal plants in Zimbabwe, by demonstrating effective models at the local level, and developing a legal framework for the ... more
 Download
  View PDF
 Add to my MEDBOX

EPI 5: Anti-epileptic medicines for medication resistant convulsive epilepsy. [New 2015]

mhGAP; WHO (2015) C_WHO
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
 Download
  View PDF
 Add to my MEDBOX

Zambia Essential Medicines List (ZEML) 05
recommended

Ministry of Health, Zambia (2020) C1
2020 Version
 Download
  View PDF
 Add to my MEDBOX

Standard Treatment Guidelines & National Essential Medicines List Tanzania Mainland

Ministry of Health, Community Development, Gender, Elderly and Children; Government of Tanzania (2018) C1
 Download
  View PDF
 Add to my MEDBOX

TB Advocacy Guide - For People who use Drugs

hit.org.uk; INPUD (2019) C2
Accessed: 19.10.2019
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection - AIDSinfo

AIDSinfo (2019) C2
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019 Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office of AIDS Research Advisory Council (OARAC)
 External Link
 Add to my MEDBOX

Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle- Income Countries: A Forecast Analysis 2015- 2025

A. Gupta; S. Juneja; M. Vitoria; et al. PLOS ONE (2016) CC
Research Article PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
 Download
  View PDF
 Add to my MEDBOX

Combined global demand forecasts for antiretroviral medicines and HIV diagnostic in low- and middle-income countries from 2015 to 2020

A. Adesina; J. Stover; M. Auton; et al. World Health Organization (2016) C_WHO
Technical Report AIDS Medicines and diagnostics service September 2016
 Add to my MEDBOX

Commisson Notice: Guidelines for the prudent use of antimicrobials in veterinary medicine

Official Journal of the European Union (2015) C2
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibio ... more
 Add to my MEDBOX

Tackling antimicrobial use and resistance in pig production: lessons learned in Denmark

Food and Agriculture Organization of the United Nations FAO (2019) C2
This publication describes an arduous campaign to tackle the use of antimicrobials - specifically antibiotics - in the Danish swine-producing sector thanks to the collaboration between the regulatory sector within the Ministry of Environment and Foo ... more
 Download
  View PDF
 Add to my MEDBOX

Situation Analysis Antibiotic Use and Resistance in India

Public Health Foundation India (2011) C2
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic ... more
 Download
  View PDF
 Add to my MEDBOX

Recommendation regarding the use of Ivermectin as a treatment for COVID-19
recommended

Pan American Health Organization PAHO, World Health Organization WHO (2020) C_WHO
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications on observational clinical studies reported the apparent utility of ivermectin to treat patients with COVID-19 needing mechanical venti ... more
 Add to my MEDBOX

Statement on herbal remedies and medicines for prevention and treatment of COVID-19

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C1
This statement aims to provide guidance and recommendation to African Union Member States in responding to the following questions: What should countries do when announcing identification of a herbal remedy or medicine? What are the implications for the rest of the continent?
 Download
  View PDF
 Add to my MEDBOX

Guidelines for emergency and compassionate use authorisation of health products and technologies

Ministry of Health, Kenya (2020) CC
 Download
  View PDF
 Add to my MEDBOX

Point-of-use fortification with micronutrient powders (mnp)improving the nutrition of infants and young children aged 6-23 months (Healthcare Providers)

Ministry of Health, Kenya (2020) C1
The micronutrient powders will be distributed at the health facilities where instructions on use will be provided by Health Care Providers. Community Health Volunteers will educate, counsel, and mobilize caregivers at the community level to visit he ... more
 Add to my MEDBOX

Point-of-use fortification with micronutrient powders (mnp)improving the nutrition of infants and young children aged 6-23 months (Community Health Volunteers))

Ministry of Health, Kenya (2020) C1
The harmonized training package for Point-of-use-fortification using micronutrient powders has been developed to guide in training frontline health workers. The micronutrient powders will be distributed at the health facilities where instructions on ... more
 Download
  View PDF
 Add to my MEDBOX

WHO guideline: the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings

World Health Organization WHO (2016) C_WHO
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
 External Link
 Add to my MEDBOX

Pharmacists' knowledge and perceptions about herbal medicines: A case study of Jos and environs

Jimann, N.S.; et al. (2017) CC
Med J DY Patil Univ 2017;10:229-33
 Download
  View PDF
 Add to my MEDBOX

Assessment of access to essential outpatient medicines in Ukraine

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Me ... more
 Add to my MEDBOX

Updates to section 6.2.5 Antituberculosis medicines of the 2021 WHO Model List of Essential Medicines

World Health Organization WHO (2022) C_WHO
 Add to my MEDBOX

Interim recommendations for use of the Valneva VLA2001 vaccine against COVID 19: interim guidance

World Health Organization WHO (2022) CC
first issued 18 August 2022
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Burkina Faso

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Cameroon

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Eswatini

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Gabon

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Ghana

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Kenya

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Malawi

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Nigeria

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Senegal

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Sierra Leone

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Tanzania

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Uganda

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Zambia

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 External Link
 Add to my MEDBOX

Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) Country Report Zimbabwe

Africa Center for Disease Control and Prevention (2023) CC
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa ... more
 Add to my MEDBOX

The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study

Khuluza, F.; Haefele-Abah, C. PLoS ONE (2019) CC
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere ... more
 Add to my MEDBOX

Manual for Medicines Good Dispensing Practice (Ethiopia)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2012) C1
 Download
  View PDF
 Add to my MEDBOX

Swaziland: Guidelines on Import and Export Procedures for Medicines

Ministry of Health, Kingdom of Swaziland (2016) C2
 Download
  View PDF
 Add to my MEDBOX

Report of the Task Force on Conservation & Sustainable use of Medicinal Plants

Government of India, Planning Commission (2000) C1
Medicinal plants occupied an important position in the socio-cultural, spiritual and medicinal arena of rural people of India. T The present report is based on contribution made by members of the task force and many other experts on medicinal plants. We hope the report on implementation will promot ... more
 Download
  View PDF
 Add to my MEDBOX

Health Systems in Action: An eHandbook for Leaders and Managers - CHAPTER 8 - Managing Medicines And Health Products

Malcolm Clark; Andy Barraclough Management Sciences for Health (2010) C1
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, whi ... more
 External Link
 Add to my MEDBOX

Situation Analysis: Antibiotic use and resistance in South Africa

The Center for Disease Dynamics, Economics & Policy CDDEP (2011) C2
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p ... more
 Download
  View PDF
 Add to my MEDBOX

Guidance for registered pharmacies preparing unlicensed medicines: revison 2018

General Pharmaceutical Council Genral Pharmaceutical Council UK (2018) CC
This guidance should be followed if an unlicensed medicine is prepared in a registered pharmacy. The preparation of an unlicensed medicine (for example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’. The guidance should be read alon ... more
 Download
  View PDF
 Add to my MEDBOX

The Interagency List of Essential Medicines for Reproductive Health

WHO (2006) C_WHO
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents the current international consensus on rational selection of essential reproductive health m ... more
 Download
  View PDF
 Add to my MEDBOX

Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended

World Health Organization WHO (2016) C_WHO
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structu ... more
 Download
  View PDF
 Add to my MEDBOX

Technical update on treatment optimization: use of tenofovir disoproxil fumarate in HIV-infected children and adolescents aged 2–18 years: a public health perspective

World Health Organization (2012)
 Download
  View PDF
 Add to my MEDBOX

National List of Essential Medicines for Adults. NEML, 6th edition, 2015 - Rwanda

Ministere de la Sante, Rwanda (2010) C_WHO
The 6th edition of the essential medicine list has been developed based on the 5th edition list of essential medicines, the National Standard Treatment Guidelines and Protocols 2013, list of laboratory commodities and List of Consumables used in pub ... more
 External Link
 Add to my MEDBOX

Medical eligibility criteria for contraceptive use (5 edition)

World Health Organization WHO (2015)
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) gu ... more
 Download
  View PDF
 Add to my MEDBOX

What You Should Know About Taking Tuberculosis Medicines

Virginia Department of Health Division of TB Control (2002) CC
 Download
  View PDF
 Add to my MEDBOX

National Guidelines for the Use of Antiretroviral Therapy in Adults and Adolescents

National Center for HIVAIDS, Dermatology and STD, Cambodia Ministry of Health (2012) CC
 Download
  View PDF
 Add to my MEDBOX

Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended

World Health Organization WHO (2011) C_WHO
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o ... more
 Download
  View PDF
 Add to my MEDBOX

Uganda: National Performance Report on Medicines Management July- September 2015

Ministry of Health, Republic of Uganda (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Nepal: National List of Essential Medicines, 2021
recommended

World Health Organisation (WHO) (2021) C_WHO
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
 Download
  View PDF
 Add to my MEDBOX

India: National List of Essential Medicines 2015

Ministry of Health & Family Welfare (MOHFW), Government of India (2015) C_WHO
 Download
  View PDF
 Add to my MEDBOX

National List of Essential Medicines for Adults Rwanda 6th edition

Republic of Rwanda, Ministry of Health (2015) C1
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the heal ... more
 Download
  View PDF
 Add to my MEDBOX

Personal protective equipment for use in a filovirus disease outbreak
recommended

World Health Organization WHO (2016) C_WHO
Rapid Advice Guideline
 Download
  View PDF
 Add to my MEDBOX

WHO guidelines on use of medically important antimicrobials in food-producing animals

World Health Organization WHO (2017) C_WHO
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA Lis ... more
 Download
  View PDF
 Add to my MEDBOX

Tanzania: National Guidelines for Monitoring Medicines Safety

Tanzania Food & Drugs Authority (TFDA) (2010) C2
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
 Download
  View PDF
 Add to my MEDBOX

SWAZILAND GUIDELINE ON DONATION OF MEDICINES

Ministry of Health, Kingdom of Swaziland (2016) C2
 Download
  View PDF
 Add to my MEDBOX

Considerations for adoption and use of multidisease testing devices in integrated laboratory networks

World Health Organization (2017) C_WHO
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepati ... more
 Download
  View PDF
 Add to my MEDBOX

WHO bes -practice statement on the off -label use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

World Health Organization WHO (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Influence of Service Readiness on Use of Facility Delivery Care: A Study Linking Health Facility Data and Population Data in Haiti

Wang, Wenjuan, Michelle Winner, Clara Burgert, and Josh Colston ICF International (2014) C2
DHS Working Papers No. 114
 External Link
 Add to my MEDBOX

International assistance for victims of use of nuclear, radiological, biological and chemical weapons: time for a reality check?

Coupland R, Loye D International Review of the Red Cross (2009) C2
The risks of the use of nuclear, radiological, biological or chemical (NRBC) weapons are heterogeneous. Each risk has its own implications for developing and deploying any capacity to assist victims of an NRBC event and, in parallel, for the health ... more
 Download
  View PDF
 Add to my MEDBOX

Assessment of Medicines Quality Assurance in Rwanda: Overview of Findings and Recommendations for Consideration

Coignez, V., Hajjou, M., and Smine U.S. Agency for International Development (USAID) (2009) C2
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato ... more
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the use of delamanid in the treatment of drug-resistant TB in India
recommended

Ministry of Health & Family Welfare, India; World Health Organization (WHO) (2018) C1
 Download
  View PDF
 Add to my MEDBOX

Prudent and efficient use of antimicrobials in pigs and poultry

Food and Agriculture Organization of the United Nations FAO (2019) C2
This manual will contribute directly to the fourth focus area of the FAO Action Plan by promoting the prevention of infections and the prudent use of antibiotics in the pig and poultry sectors. The pig and poultry sectors are addressed together, as ... more
 External Link
 Add to my MEDBOX

Guide to Prudent Use of Antimicrobial Agents in Dairy Production

International Dairy Federation (2013) C2
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emer ... more
 Add to my MEDBOX

Guidelines for the use of antibiotics in production animals: Cattle, pigs, sheep and goats

The Swedish Veterinary Association SVS (2017) C2
In 1998 the Swedish Veterinary Association decided to adopt a general policy for the use of antibiotics in animals. Since then specifi c policies for the use of antibiotics in dogs and cats have bee ... more
 Download
  View PDF
 Add to my MEDBOX

Situation Analysis and Recommendation: Antibiotic Use and Resistance in Tanzania

Aboud S., R. Mdegela Global Antibiotic Resistance Partnership—Tanzania Working Group (2015) C2
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ... more
 Add to my MEDBOX

Situation Analysis and Recommendations: Antibiotic Use and Resitance in Mozambique

The Center for Disease Dynamics, Economics & Policy CDDEP (2015) C2
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate ... more
 Download
  View PDF
 Add to my MEDBOX

Situation Analysis and Recommendations: Antibiotic Use and Resistance in Nepal

Nepal Public Health Foundation (2015) C2
Antibiotic resistance is no longer a concern for the distant future but is a pressing issue, both globally and in Nepal. As part of global effort to preserve the effectiveness of antibiotics, the Global Antibiotic Resistance Partnership (GARP)-Nepal was established to doc ... more
 Add to my MEDBOX

Handbook for the use of digital technologies to support tuberculosis medication adherence

World Health Organization WHO (2017) C_WHO
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support ... more
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine

World Health Organization WHO (2022) C_WHO
6 June 2022 These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included ... more
 Download
  View PDF
 Add to my MEDBOX

African Union and the Africa CDC’s Africa Regulatory Taskforce has endorsed the Emergency Use Authorisation for COVID-19 Vaccine BIBP/ Sinopharm

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing ... more
 Add to my MEDBOX

African Union and the Africa CDC’s Africa Regulatory Taskforce has endorsed the Emergency Use Authorisation of Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing ... more
 Download
  View PDF
 Add to my MEDBOX

Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19: interim guidance, 20 December 2021

World Health Organization WHO (2022) C_WHO
27 September 2022 These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b ... more
 External Link
 Add to my MEDBOX

The OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials

World Organisation for Animal Health (2016) C2
The OIE has been working on the AMR issue for a long time. In undertaking its role as a standard- setting organisation* for animal health, including zoonoses, the OIE has developed a wide range of international standards on antimicrobial agents, in particular on responsible and prudent ... more
 Add to my MEDBOX

Considerations on the Use of Antivirals, Monoclonal Antibodies, and Other Interventions for the Management of COVID-19 Patients in Latin America and the Caribbean

World Health Organization WHO; PAHO; et al. (2022) CC
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently, ... more
 Download
  View PDF
 Add to my MEDBOX

Good practice statement on the use of variant-containing COVID-19 vaccines

World Health Organization WHO (2022) C_WHO
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID- ... more